Abstract
Discordances between minimal residual disease estimates obtained by different methods are a problem in childhood acute lymphoblastic leukemia. We aimed to optimize methods allowing the biological exploration of such discrepancies, i.e. the combination of flow-sorting of small immunophenotypically defined cell populations with subsequent analyses of leukemia-associated cytogenetic and molecular marker. The approaches described here optimize the use of the same tube of unfixed, antibody-stained BM cells for flow-sorting of small cell populations and subsequent exploratory FISH and PCR-based analyses.
Copyright © 2011 Elsevier B.V. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Bone Marrow / chemistry*
-
Bone Marrow / immunology
-
Cell Separation / methods*
-
Child
-
Cytogenetics / methods*
-
Flow Cytometry / methods*
-
Humans
-
Immunoglobulin G / immunology
-
In Situ Hybridization, Fluorescence / methods*
-
Neoplasm, Residual / chemistry
-
Neoplasm, Residual / immunology
-
Polymerase Chain Reaction / methods*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / immunology*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology
-
Receptors, Antigen, T-Cell / immunology
Substances
-
Immunoglobulin G
-
Receptors, Antigen, T-Cell